Treatment of chronic hepatitis B: a need for consensus
- PMID: 10029270
- DOI: 10.1046/j.1440-1746.1999.01813.x
Treatment of chronic hepatitis B: a need for consensus
Comment on
-
Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective.J Gastroenterol Hepatol. 1999 Jan;14(1):3-12. doi: 10.1046/j.1440-1746.1999.01812.x. J Gastroenterol Hepatol. 1999. PMID: 10029271
Similar articles
-
Thymalfasin in the treatment of hepatitis B and C.Ann N Y Acad Sci. 2010 Apr;1194:141-6. doi: 10.1111/j.1749-6632.2010.05487.x. Ann N Y Acad Sci. 2010. PMID: 20536462 Review.
-
Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.J Gastroenterol Hepatol. 2004 Dec;19(12):S73-5. J Gastroenterol Hepatol. 2004. PMID: 15641208 Review.
-
[Effects of lamivudine and thymosin alpha1 combination therapy on patients with chronic hepatitis B].Zhonghua Gan Zang Bing Za Zhi. 2002 Jun;10(3):218-9. Zhonghua Gan Zang Bing Za Zhi. 2002. PMID: 12113684 Chinese. No abstract available.
-
The effect of thymosine 1 alpha and Lamivudine combination therapy in chronic hepatitis B patients.Indian Pediatr. 2002 Jul;39(7):701-2. Indian Pediatr. 2002. PMID: 12147907 No abstract available.
-
Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection.Hepatogastroenterology. 2006 Mar-Apr;53(68):249-52. Hepatogastroenterology. 2006. PMID: 16608033 Clinical Trial.
Cited by
-
Effects of Zhaoyangwan on chronic hepatitis B and posthepatic cirrhosis.World J Gastroenterol. 2004 Jan 15;10(2):295-8. doi: 10.3748/wjg.v10.i2.295. World J Gastroenterol. 2004. PMID: 14716843 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources